Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 14:17:04 UTC
Update Date2021-09-26 23:09:07 UTC
HMDB IDHMDB0254828
Secondary Accession NumbersNone
Metabolite Identification
Common NameMofebutazone
DescriptionMofebutazone, also known as monazone or 2 FDBP, belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system consisting of benzene. Based on a literature review a significant number of articles have been published on Mofebutazone. This compound has been identified in human blood as reported by (PMID: 31557052 ). Mofebutazone is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Mofebutazone is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
1-Phenyl-4-butyl-3,5-pyrazolidinedioneChEBI
2 FDBPChEBI
2-Phenyl-3,5-dihydroxy-4-butylpyrazolidineChEBI
4-Butyl-1-phenyl-3,5-dioxopyrazolidineChEBI
4-Butyl-1-phenyl-3,5-pyrazolidinedioneChEBI
MofebutazonaChEBI
MofebutazonumChEBI
MonazoneChEBI
MonophenylbutazoneChEBI
MophebutazoneChEBI
NabumetoneChEBI
MofebutazoneMeSH
Mofesal NMeSH
Monophenylbutazone, sodium saltMeSH
1-Phenyl-4-N-butyl-3,5-dioxopyrazolidineMeSH
Chemical FormulaC13H16N2O2
Average Molecular Weight232.283
Monoisotopic Molecular Weight232.121177763
IUPAC Name4-butyl-3-hydroxy-1-phenyl-4,5-dihydro-1H-pyrazol-5-one
Traditional Namemozol
CAS Registry NumberNot Available
SMILES
CCCCC1C(O)=NN(C1=O)C1=CC=CC=C1
InChI Identifier
InChI=1S/C13H16N2O2/c1-2-3-9-11-12(16)14-15(13(11)17)10-7-5-4-6-8-10/h4-8,11H,2-3,9H2,1H3,(H,14,16)
InChI KeyREOJLIXKJWXUGB-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system consisting of benzene.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassNot Available
Direct ParentBenzene and substituted derivatives
Alternative Parents
Substituents
  • Monocyclic benzene moiety
  • Pyrazolidinone
  • 1,3-dicarbonyl compound
  • Pyrazolidine
  • Carboxylic acid hydrazide
  • Azacycle
  • Organoheterocyclic compound
  • Carboxylic acid derivative
  • Organic oxide
  • Organopnictogen compound
  • Organic oxygen compound
  • Organooxygen compound
  • Organonitrogen compound
  • Carbonyl group
  • Organic nitrogen compound
  • Hydrocarbon derivative
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP1.53ALOGPS
logP3.07ChemAxon
logS-2.7ALOGPS
pKa (Strongest Acidic)3.83ChemAxon
pKa (Strongest Basic)-3.1ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area52.9 ŲChemAxon
Rotatable Bond Count4ChemAxon
Refractivity64.61 m³·mol⁻¹ChemAxon
Polarizability25.17 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+161.25230932474
DeepCCS[M-H]-158.89430932474
DeepCCS[M-2H]-191.7830932474
DeepCCS[M+Na]+167.34530932474
AllCCS[M+H]+154.232859911
AllCCS[M+H-H2O]+150.432859911
AllCCS[M+NH4]+157.832859911
AllCCS[M+Na]+158.832859911
AllCCS[M-H]-157.432859911
AllCCS[M+Na-2H]-157.632859911
AllCCS[M+HCOO]-157.932859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
MofebutazoneCCCCC1C(O)=NN(C1=O)C1=CC=CC=C13122.6Standard polar33892256
MofebutazoneCCCCC1C(O)=NN(C1=O)C1=CC=CC=C12074.5Standard non polar33892256
MofebutazoneCCCCC1C(O)=NN(C1=O)C1=CC=CC=C11998.1Semi standard non polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Mofebutazone GC-MS (Non-derivatized) - 70eV, Positivesplash10-0kbf-9550000000-ac601c69eb5b7fe709f72021-09-24Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Mofebutazone GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Mofebutazone GC-MS (TMS_1_1) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Mofebutazone GC-MS (TBDMS_1_1) - 70eV, PositiveNot Available2021-11-04Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mofebutazone 10V, Positive-QTOFsplash10-001i-1290000000-87f846d1fede9337231a2016-08-02Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mofebutazone 20V, Positive-QTOFsplash10-030u-9840000000-30fd58f270c54b5ded3c2016-08-02Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mofebutazone 40V, Positive-QTOFsplash10-00kf-9100000000-f51ae44c4883c3bd565e2016-08-02Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mofebutazone 10V, Negative-QTOFsplash10-001i-0190000000-8d1836f3268ad95190b72016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mofebutazone 20V, Negative-QTOFsplash10-01ox-9650000000-765dd1df8cb22f0cb6ff2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mofebutazone 40V, Negative-QTOFsplash10-00kf-9400000000-ec885019f1617d3044062016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mofebutazone 10V, Positive-QTOFsplash10-001i-0090000000-81d7d770f98dde50e8242021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mofebutazone 20V, Positive-QTOFsplash10-001l-2980000000-4277ecf30deadba3cfc32021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mofebutazone 40V, Positive-QTOFsplash10-00ou-9100000000-11a985e2e79d8cd23b512021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mofebutazone 10V, Negative-QTOFsplash10-001i-0090000000-662f7b5a22c8f359e5122021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mofebutazone 20V, Negative-QTOFsplash10-001i-2490000000-d741bf936a3392a5d68d2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Mofebutazone 40V, Negative-QTOFsplash10-0006-9410000000-e68f7067e09669cdb0192021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB13629
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID15776
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkMofebutazone
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI ID76252
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]